Therapeutic Treatment of Dermatologic Skin Disorders
β-glucans are incorporated with liposomes in therapeutic compositions for topical application to prevent or alleviate the conditions and symptoms of cosmetic and dermatologic disorders. In particular, β-glucan is combined with liposomes to increase the penetration of the β-glucan into the skin, to provide hydration of the skin during treatment. The deeper penetration of the β-glucan increases macrophage activity to remove scar tissue, dead skin cells and other foreign debris as well as stimulating collagen growth to improve skin health.
1 . A method for increasing the transdermal penetration of β-glucans compounds from a topical skin care application, said method comprising the steps of:
providing a β-glucan compound in the skin care application; and
providing said β-glucan compound within a liposome compound to increase the transdermal penetration of said β-glucan compound.
2 . The method for increasing the transdermal penetration providing β-glucan from a topical skin care application of claim 1 wherein step of providing said β-glucan compound includes:
providing β-glucan having linkages at 1 and 3.
3 . The method for increasing the transdermal penetration of β-glucan from a topical skin care application of claim 1 wherein step of providing said β-glucan compound includes:
providing β-glucan having linkages at 1 and 3 and side linkages at 1 and 6.
4 . The method for increasing the transdermal penetration of β-glucan from a topical skin care application of claim 1 wherein step of providing said β-glucan compound includes:
providing said β-glucan compound in the range of between 0.1 percent to 20 percent by weight.
5 . The method for increasing the transdermal penetration of β-glucan from a topical skin care application of claim 1 wherein step of providing said β-glucan compound includes:
providing lipid compounds having enhanced penetration properties.
6 . The method for increasing the transdermal penetration of β-glucan from a topical skin care application of claim 1 wherein step of providing said β-glucan compound includes:
providing said liposome compound in the range of 0.1 percent to 20 percent by weight.
7 . The method for increasing the transdermal penetration of β-glucan from a topical skin care application of claim 1 wherein step of providing said β-glucan compound includes:
providing a lipid compound having a high affinity for water.
8 . A topical composition for therapeutic treatment of skin, said composition comprising:
a liposomal compound; and
a β-glucan compound contained within said liposomal compound.
9 . The topical composition of claim 8 wherein said β-glucan compound includes:
β-glucan having linkages at 1 and 3.
10 . The topical composition of claim 8 wherein said β-glucan compound includes:
β-glucan having linkages at 1 and 3 and side linkages at 1 and 6.
11 . The topical composition of claim 8 wherein said composition includes:
β-glucan compound in a range of between 0.1 and 20 percent by weight.
12 . The topical composition of claim 8 wherein said composition includes:
said liposomal compound has a high affinity for water.
13 . A method for removing scar tissue from damaged skin, said method comprising:
providing a liposomal compound;
providing a β-glucan compound contained within said liposomal compound;
applying said β-glucan compound contained within said liposomal compound to the damaged skin.
14 . The method for removing scar tissue from damaged skin of claim 13 wherein step of providing said β-glucan compound includes:
providing β-glucan having linkages at 1 and 3.
15 . The method for removing scar tissue from damaged skin of claim 13 wherein step of providing said β-glucan compound includes:
providing β-glucan having linkages at 1 and 3 and side linkages at 1 and 6.
16 . The method for removing scar tissue from damaged skin of claim 13 wherein step of providing said β-glucan compound includes:
providing said β-glucan compound in the range of between 0.1 percent to 20 percent by weight.
17 . A method for treating basal cell carcinoma, said method comprising:
providing a liposomal compound;
providing a β-glucan compound contained within said liposomal compound;
applying said β-glucan compound contained within said liposomal compound to the basal cell carcinoma in the skin.
18 . The method for treating basal cell carcinoma of claim 17 wherein step of providing said β-glucan compound includes:
providing β-glucan having linkages at 1 and 3.
19 . The method for treating basal cell carcinoma of claim 17 wherein step of providing said β-glucan compound includes:
providing β-glucan having linkages at 1 and 3 and side linkages at 1 and 6.
20 . The method for treating basal cell carcinoma of claim 17 wherein step of providing said β-glucan compound includes:
providing said β-glucan compound in the range of between 0.1 percent to 20 percent by weight.